In this video, Jennifer A. Ligibel, MD, discusses the phase 3 CHALLENGE study evaluating the impact of structured exercise on disease-free survival for stage 3 or high-risk stage 2 colon cancer, ...

Atezolizumab plus mFOLFOX6 is a practice-changing and new standard treatment for patients with dMMR stage III colon cancer,” said Frank Sinicrope, MD.

Despite current progress in the development of targeted therapies for cancer treatment, there is a lack in convenient ... profile of the encapsulated NPs triggered by stimuli in the colon. Here, we ...